Acetazolamide-enhanced neuroSPECT scan reveals functional impairment after minimal traumatic brain injury not otherwise discernible

Psychiatry Res. 2004 Dec 30;132(3):279-83. doi: 10.1016/j.pscychresns.2004.09.004.

Abstract

A patient suffering from aggressive personality changes and cognitive impairment following head trauma, without neurological or anatomical imaging findings, underwent neuroSPECT scans with and without acetazolamide injection, both before treatment and during treatment with valproate. Acetazolamide injection induced increased prefrontal perfusion not evident at baseline. Valproate treatment was associated with increased prefrontal perfusion concomitant with clinical improvement and abolished response to acetazolamide challenge.

Publication types

  • Case Reports

MeSH terms

  • Acetazolamide / pharmacology*
  • Acetazolamide / therapeutic use
  • Adult
  • Brain / blood supply*
  • Brain Injuries / complications
  • Brain Injuries / diagnosis*
  • Brain Injuries / drug therapy*
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Carbonic Anhydrase Inhibitors / therapeutic use
  • Cognition Disorders / diagnosis
  • Cognition Disorders / etiology
  • Humans
  • Male
  • Neuropsychological Tests
  • Personality Disorders / diagnosis
  • Personality Disorders / etiology
  • Regional Blood Flow / drug effects
  • Tomography, Emission-Computed, Single-Photon*
  • Valproic Acid / pharmacology*
  • Valproic Acid / therapeutic use

Substances

  • Carbonic Anhydrase Inhibitors
  • Valproic Acid
  • Acetazolamide